Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: Glucocorticoids and cyclosporine

Journal of Drug Targeting

Volumn 7, Issue 2, 1999, Pages 79-99

  Klyashchitsky, Boris A ^a   Owen, Albert J ^a  

^a LDS Technologies Inc   (United States)

Author keywords

Cyclosporine; Glucocorticoids; Inhalation; Liquid formulations; Lung diseases treatment; Nebulizers; Pulmonary delivery

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CYCLOSPORIN; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; FLUNISOLIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LIPOSOME; ORGANIC SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; GRAFT REJECTION; HUMAN; HYDROPHOBICITY; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; LUNG TRANSPLANTATION; META ANALYSIS; NEBULIZATION; NEBULIZER; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032700302     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869909085494     Document Type: Review

References (83)

1. Alexander, A.G., Barnes, N.C. and Kay, A.B. (1992) Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet, 339, 324-328.
2. Arppe, J., Vidgren, M. and Waldrep, J.C. (1998) Pulmonary pharmacokinetics of cyclosporin A liposomes. Intern. J. Pharm., 161, 205-214.
3. Axelsson, B.I., Brattsand, R.L., Dahlback, C.M.O., Kallstrom, L.A. and Trofast, J.W. Liposomes containing steroid esters. US Patent 4693999, 15 Sept. 1987.
4. Aziz, S., Bieber, C.P., Reitz, B.A., Bieber, M.M., Oyer, P.E., Hogt, G. and Stinson, E.B. (1981) Preparation and efficacy of cyclosporin A liposomes lor prolongation of cardiac allograft survival. Transplant. Proc., 13, 410-411.
5. Benjamin, E., Anik, S. and Lin, Y.-Y.T. Aqueous steroid formulations for nasal administration. US Patent 4782047, 1 Nov. 1988.
6. Blot, F., Tavakoli, R., Sellam, S.. Epardeau, B., Faurisson, F., Bernard, N., Becquemin, M.H., Frachon, I., Stern, M., Pocidalo, J.J., Carbon, C., Bisson, A. and Caubarrere, I. (1995) Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmaeokinetic and histologic study. J. Heart Lung Transplant., 14, 1162-1172.
7. Bridges, P.A., Taylor, K.M.G. and McCallion, O.N.M. (1995) The effect of lipid concentration on the nebulization of liposomes. Proc. Int. Symp. Controlled Release Bioact. Mater., 22nd, 440-441.
8. Bridges, P.A. and Taylor, K.M.G. (1998) Nebulizers for the generation of liposomal aerosol. Int. J. Pharm., 173, 117-125.
9. Calderon, E., Lockey, R.F., Bukant, Z.S.C., Caffey, R.G. and Ledford, O.K. (1992) Is there a role for cyclosporin in asthma? J. Allergy Clin, Immunol., 89, 629-636.
10. Ceyhan, B.B., Sungur, M., Celikel, C.A. and Celikel, T. (1998) Effect of inhaled cyclosporin on the rat airway: histological and bronchoalveolar lavage assessment. Respiration, 65, 71-78.
11. Choice, E., Masin, D., Bally, M.B., Melohe, M. and Madden, T.D. (1995) Liposomal cyclosporin. Comparison of drug and lipid carrier pharmacokinetics and biodistribution. Transplantation, 60, 1006-1011.
12. Derendorf, H. (1997) Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety. Respiratory Med., 91(Suppl.A). 22-28.
13. Dingle, J.T., Gordon, J.L., Jones, G., Knight, C.G. and Lowe, J.S. Pharmaceutical compositions. US Patent 4427649, 24 Jan. 1984.
14. Dowling, R.D., Zenati, M., Burchard, G.J., Yousem, S.A., Schaper, M., Simmons, R.L., Hardesty, R.L. and Griffith, B.P. (1990) Aerosolized cyclosporin as single-agent immunotherapy in canine lung allografts. Surgery, 108, 198-205.
15. Duncan, S.R., O'Riordan, T.G., Smaldone, G.C., Yousem, S.A., Zeevi, A., Burckart, G.J., Keenan, R. and Griffith, B. (1993) Aerosolized cyclosporine for the treatment of refractory chronic lung rejection: a preliminary report (abstract). Am. Rev. Respir. Dis., 147, 198.
16. Fahr, A., Holz, M. and Fricker, G. (1995) Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics. Pharm. Res., 12, 1189-1198.
17. Finlay, W.H., Stapleton, K.W. and Zuberbuchler, P. (1997) Predicting regional lung dosages of a nebulized suspension: Pulmicort (budesonide). Part. Sci. Technol., 15, 243-251.
18. Foe, K., Cheung, H.T.A., Tattam, B.N., Brown, K.F. and Seale, J.P. (1997) Degradation products of beclomethasone dipropionate in human plasma. Drug Metab. Dispos., 26, 132-137.
19. Foe, K., Brownm K.F. and Seale, J.P. (1998) Decomposition of beclomethasone propionate esters in human plasma. Biopharm. Drug Dispos., 19, 1-8.
20. Forsgren, P.E., Modig, J.A., Dahlback, C.M.O. and Axelsson, B.I. (1990) Prophylactic treatment with an acrosolized corticosteroid liposome in a porcine model of early ARDS induced by endotoxaemia. Acta Chir. Scand., 156, 423-431.
21. Ganderton, D. (1997) General factors influencing drug delivery to the lung. Respiratory Med., 91 (Suppl. A), 13-16.
22. Gilbert, B.E., Black, M.B., Waldrep, J.C., Bennick, J.B., Miontgomery, C. and Knight, V. (1997a) Cyclosporin A liposome aerosol: lack of acute toxicity in rats. Inhalation Toxicol., 9, 717-730.
23. Gilbert, B.E., Eschenbacher, W.L., Knight, V., Rodarte, J.R., Waldrep, J.C., Alvarez, F.G. and Knight, C. (1997b) Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol. Am. J. Respir. Crit. Care Med., 156, 1789-1793.
24. Gilbert, B.E., Wilson, S.Z., Garcon, N.M., Wyde, P.R. and Knight, V. (1993) Characterization and administration of cyclosporine liposomes as a small particle aerosol. Transplantation, 56, 974-977.
25. Gonzalez-Rothi, R.J., Suarez, S., Hochhaus, G., Schreier, H., Lukyanov, A., Derendorf, H. and Dalla Costa, T. (1996) Pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm. Res., 13, 1699-1703.
26. Gonzalez-Rothi, R. J. and Schreier, H. (1995) Pulmonary delivery of liposoine-encapsulated drugs in asthma therapy. Clin. Immunother., 4, 331-337.
27. Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. and Gilman, A.G., Eds. (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics (New York: McGraw-Hill), pp. 1475-1476.
28. Hochhaus, G., Mollmann, H., Derendorf, H. and Gonzalez-Rothi, R.J. (1997) Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model. J.Clin. Pharmacol., 37, 881-892.
29. Hochhaus, G., Gonzalez-Rothi, R.J., Lukyanov, A., Derendorf, H., Schreier, H. and Dalla Costa, T. (1995) Assessment of glucocorticoid lung targeting by ex-vivo receptor binding studies in rats. Pharm. Res., 12, 134-137.
30. Hou, S., Hindle, M. and Byron, P.R. (1998) Solution stability of budesonide in novel aerosol formulations. Abstracts of 1998 AAPS Annual Meeting, p. S307, San Francisco.
31. Iacono, A.T., Keenan, R.J., Duncan, S.R., Smaldone, G.S., Dauber, J.H., Paradis, I.L., Ohori, N.P., Grgurish, W.F., Burckart, G.J., Zeevi, A., Deldago, E., O'Riordan, T.G., Zendarsky, M.M., Yousem, S.A. and Griffith, B.P. (1996) Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Amer. J. Respir. Crit. Care Med., 153, 1451-1455.
32. Iacono, A.T., Smaldone, G.C., Keenan, R.J., Diot, P., Dauber, J.H., Zeevi, A., Burckart, G.J. and Griffith, B.P. (1997) Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Amer. J. Respir. Crit. Care Med., 155, 1690-1698.
33. Keenan, R.J., Duncan, A.J., Yousem, S.A., Zenati, M., Schper M., Dowling, R.D., Alarie, Y., Burckart, G.J. and Griffith, B.P. (1992) Improved immunosuppression with aerosolized cyclopsorin in experimental pulmonary transplantation. Transplant. Proc., 53, 20-25.
34. Keenan, R.J., Iacono, A., Dauber, J.H., Zeevi, A., Yousem, S.A., Ohori, N.P., Burckart, G.J., Kawai, A., Smaldone, G.C. and Griffith, B.P. (1997) Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. J. Thorac. Cardiovasc. Surg., 113, 335-341.
35. Keenan, R.J., Zeevi, A., Iacono, A.T., Spichty, K.J., Cai, J.Z., Yousem, S.A., Ohori, N.P., Paradis, I.L., Kawai, A. and Griffith, B.P. (1995) Efficacy of inhaled cyclosporine in lung transplant recipients with refractory refection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics. Surgery, 118, 385-391.
36. Klyashchitsky, B.A. and Owen, A.J. (1998) Drug delivery systems for cyclosporine: achievements and complications. J. Drug Targeting, 5, 443-458.
37. Klyashchitsky, B.A., Saldi, Z., Saar, A., Sedlak, D., Szymkowiak, J. and Owen, A. (1999) Nebulizer-compatible liquid formulations for pulmonary delivery of glucocorticoids: pre-formulation studies. Proceed. Intern. Symp. Control Rel. Bioact. Mater., 26, Boston 20-23 June, pp. 571-572.
38. Knight, C.M., Gilbert, C.M., Waldrep, J.C., Black, M.B., Knight, J.V. and Eschenbacher, W.L. (1994) Inhalation of a corticisteroid-liposome preparation by normal subjects causes no adverse effects. American Thoracic Society/American Lung Association, May 22-25, 4, A220.
39. Knight, V. and Waldrep, J.C. (1996) New approaches in aerosol drug delivery for the treatment of asthma. In: Kay, A.B. (Ed.), All. Allergic Dis., Blackwell Science, Oxford, pp. 726-737.
40. Lagente, V., Carre, C., Kyriacopoulos, F., Boichot, E., Mencia-Huerta, J.M. and Braquet, P. (1994) Inhibitory effect of cyclosporine A on eosinophil infiltration in the guinea-pig lung induced by antigen, platelet activating factor and leukotriene B4. Europ. Pespir. J., 7, 921-926.
41. Lock, S.H., Kay, A.B. and Barnes, N.C. (1996) Double blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Respir. Crit. Care Med., 153, 509-514.
42. Malcolmson, C. and Lawrence, M.J. (1993) A comparison of the incorporation of model steroids into non-ionic micellar and microemulsion system. J. Pharm. Pharmacol., 45, 141-143.
43. Malcolmson, C., Satra, C., Kantaria, S., Sidhu, A. and Lawrence, M.J. (1998) Effect oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. J. Pharm. Sci., 87, 109-116.
44. Martinet, Y., Pinkston, P., Saltini, C., Spurzem, J., Muller-Quernheim, J. and Crystal, R.G. (1988) Evaluation of the in vitro and in vivo effects of cyclosporin on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am. Rev. Respir. Dis., 138, 1242-1248.
45. McCallion, O.N.M. and Patel, M.J. (1996a) Viscosity effects on nebulization of aqueous solutions. Int. J. Pharm., 130, 245-249.
46. McCallion, O.N.M., Taylor, K.M.G., Bridges, P.A., Thomas, M. and Taylor, A.J. (1996b) Jet nebulizers for pulmonary drug delivery. Int. J. Pharm., 130, 1-11.
47. McCallion, O.N.M., Taylor, K.M.G., Thomas, M. and Taylor, A.J. (1996c) The influence of surface tension on aerosols produced by medical nebulizers. Int. J. Pharm., 129, 123-136.
48. McCallion, O.N.M., Taylor, K.M.G., Thomas, M. and Taylor, A.J. (1995) Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm. Res., 12, 1682-1688.
49. Morley, J. (1992) Cyclosporin in asthma therapy: a pharmacological rationale. J. Autoimmun., 5(Suppl. A), 265-269.
50. Muggenburg, B.A., Hoover, M.D., Griffith, B.P., Haley, P., Snipes, M.B., Wolff, R.K., Yeh, H.C., Burckart, G.J. and Mauderly, J.L. (1990) Administration of cyelosporine by inhalation: a feasibility study in beagle dogs. J. Aerosol. Med., 3, 1-13.
51. NIH Publication No. 97-4053. Practical Guide for the diagnosis and management of asthma. October 1997.
52. Nikander, K. (1994) Drug delivery systems. J. Aer. Med., 7, 519-524.
53. Nizankowska, E., Soja, J., Pinis, G., Bochenek, G., Sladek, K., Domogala, B., Pajak, A. and Szczeklik, A. (1995) Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur. Respir. J., 8, 1091-1099.
54. O'Riordan, T.G. Duncan, S.R., Burckart, G.J., Griffith, B.P. and Smaldone, G.C. (1992) Characterization of an aerosol of cyclosporine as a prelude to clinical studies. J. Aerosol Med., 5, 171-177.
55. O'Riordan, T.G., Iacono, A., Keenan, R.J., Duncan, S.R., Burckart, G.J., Griffith, B.P. and Smaldone, G.C. (1995) Delivery and distribution of aerosolized cyclosporine in lung allograft recipients. Am. J. Respir. Crit. Care Med., 151, 516-521.
56. O'Riordan, T.G., Waldrep, J.C., Abraham, W.M., Mao, Y., Sabater, J.R., Sielczak, M. and Knight, V. (1997) Delivery of nebulized budesonide liposomes to the respiratory tract of allergic sheep. J. Aerosol Med., 10, 117-128.
57. Ouyang, S., Choice, E., Holland, J., Meloche, M. and Madden, T.D. (1995) Liposomal cyelosporine. Characterization of drug incorporation and interbilayer exchange. Transplantation, 60, 999-1006.
58. Person, D.D., Hess, G.D., Muller, W.J. and Scherer, P.W. (1987) Airway deposition of hygroscopic heterodispersed aerosols: results of a computer model. J. Appl. Physiol., 63, 1195-1204.
59. Radhakrishnan, R. Novel liposome composition for sustained release of steroidal drugs in lungs. US Patent 4906476. 6 March 1990.
60. Radhakrishnan, R. Novel liposome composition for sustained release of steroidal drugs. US Patent 5043165. 27 Aug. 1991a.
61. Radhakrishnan, R. Novel liposome composition for the treatment of interstitial lung diseases. US Patent 5049389. 17 Sept. 1991b.
62. Radhakrishnan, R., Mihalko, P.J. and Abra, R.M. Pharmaceutical liposomes containing corlicosteroids. US 5192528, 9 March 1993.
63. 99mTc-labelled beclomethasone-DLPC liposomes in mild and severe asthma. Chest, 113, 1573-1579.
64. Saidi, Z., Klyashchitsky, B., Sedlak, D., Saar, A., Szymkowiuk, J., Collier, K. and Owen, A. (1999) Novel liquid formulations for pulmonary delivery of beclomethasone dipropionate with nebulizers. Proceed. Intern. Symp. Control Rel. Bioact. Mater., 26, Boston 20-23 June, pp. 78-79.
65. Satra, C., Thomas, M. and Lawrence, M.J. (1995) Formulating oil-in-water mieroemulsions for pulmonary drug delivery. Drug Delivery to the Lung 17, London. The Aerosol Society (Bristol), pp. 40-43.
66. Schreier, H., Gonzalez-Rothi, R.J. and Stecenko, A.A. (1993) Pulmonary delivery of liposomes. J. Controlled Rel. 24, 209-223.
67. Schreier, H., Lukyanov, A.N., Hochhaus, G. and Gonzalez-Rothi, R.J. (1994) Thermodynamic and kinetic aspects of the interaction of triamcinolone acetonide with liposomes. Proceed. Intern. Symp. Control Rel. Bioact. Mater., 21, 228-229.
68. Steckel, H. and Muller, B.W. (1998) Metered-dose inhaler formulation of fluticasone-17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227. Int. J. Pharm., 173, 25-33.
69. Suarez, S., Gonzalez-Rothi, R.J., Schreier, H. and Hochhaus, G. (1998) Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm. Res., 15, 461-465.
70. Szczeklik, A., Nizankowska, E., Dworski, R , Domagala, B. and Pinis, G. (1991) Cyclosporin for steroid-dependent asthma. Allergy, 46, 312-315.
71. Taniguchi, K., Yamazawa, N., Itakura, K., Morisaki, K. and Hayashi, S. (1987) Partition characteristics of anti-inflammatory steroids in liposonial ophtalmic preparations. Chim. Pharm Bull., 35, 1214-1222.
72. Taylor, K., M.G. and Farr, S.G. (1993) Liposomes for drug delivery to the respiratory tract. Drug Dev. Ind. Pharm. 19, 123-142.
73. Tremblay, G.M., Therien, H.M., Rocheleau, H. and Cormier, Y. (1993) Liposonial dexamethasone effectiveness in the treatment of hypersensitivity pneumonitis in mice. Eur. J. Clin. Investig., 23, 656-661.
74. 99mTechnetium-labelled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers. Intern. J. Pharm., 115, 209-216.
75. Waldrep, J.C., Scherer, P.W., Keyhani, K. and Knight, V. (1993a) Experimental lung therapy using drug-liposome aerosols. J. Am. Rev. Respir. Dis., 147, A289.
76. Waldrep, J.C., Scheren, P.W., Keyhani, K. and Knight, V. (1991b) Cyclosporin A liposome aerosol: particle size and calculated respiratory deposition. Im. J. Pharm., 97, 205-212.
77. Waldrep, J.C., Keyhani, K., Black, M. and Knight, V. (1994a) Operating characteristic of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest, 105, 106-110.
78. Waldrep, J.C., Scherer, P.W., Dale Hess, G., Black, M. and Knight, V. (1994b) Nebulized Glucocorticoids in liposomes: aerosol characteristic and human dose estimates. J. Aerosol Med. 7, 135-145.
79. Waldrep, J.C., Arppe, J., Jansa, K.A. and Knight, V. (1997a) High dose cyclosporin A and budesonide-liposome aerosol. Int. J. Pharm., 152, 27-36.
80. Waldrep, J.C., Gilbert, B.E., Knight, C.M., Black, M.B., Scherer, P., Knight, V. and Eschenbacher, W. (1997b) Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Chest, 111, 316-323.
81. Waldrep, J.C., Arppe, J., Jansa, K.A. and Vidgren, M. (1998) Experimental pulmonary delivery of cyclosporin A by liposome aerosol. Int. J. Pharm., 160, 239-249.
82. Warisnoicharoen, W., Lansley, A.B. and Lawrence, M.J. (1995) The cytotoxicity of nonionic oil-in-water microemulsions to a human lung cell line. Drug Delivery to the Lung VI, London. The Aerosol Society (Bristol), pp. 134-137.
83. Weber, T., Kalbhenn, T., Herrmann, G. and Hanisch, E. (1997) Local immuno-suppression with budesonide after liver transplantation in the rat: a preliminary histomorphological analysis. Transplantation, 64, 705-708.